Drug interactions
Donepezil transdermal + Indacaterol-glycopyrronium
Severity: Moderate
Donepezil transdermal and Indacaterol-glycopyrronium: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Donepezil increases cholinergic activity while glycopyrronium blocks muscarinic receptors, so each may reduce the effect of the other. Donepezil may also cause bradycardia, which is a separate concern with beta2-agonists affecting rhythm.
What this interaction means in plain words
Donepezil transdermal and Indacaterol-glycopyrronium can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Why it happens
Pharmacodynamic antagonism between a cholinesterase inhibitor and an antimuscarinic.
What to do
Monitor cognitive response and heart rate. Prefer non-anticholinergic bronchodilators if cognitive benefit declines.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Donepezil transdermal and Indacaterol-glycopyrronium, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Indacaterol-glycopyrronium
Frequently asked questions
Can I take Donepezil transdermal with Indacaterol-glycopyrronium?
MediHelp rates the interaction as moderate. Donepezil transdermal and Indacaterol-glycopyrronium can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Donepezil increases cholinergic activity while glycopyrronium blocks muscarinic receptors, so each may reduce the effect of the other. Donepezil may also cause bradycardia, which is a separate concern with beta2-agonists affecting rhythm.
How serious is the interaction between Donepezil transdermal and Indacaterol-glycopyrronium?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor cognitive response and heart rate. Prefer non-anticholinergic bronchodilators if cognitive benefit declines.
What other medicines interact with Indacaterol-glycopyrronium?
MediHelp also lists interactions of Indacaterol-glycopyrronium with, for example, Amisulpride, Arformoterol, Arsenic trioxide. The full list is on the Indacaterol-glycopyrronium page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
